Ivermectina – ACMS | Academia de Ciencias Médicas de Santa Fe https://acacimesfe.org Wed, 03 Feb 2021 13:46:17 +0000 es-MX hourly 1 https://acacimesfe.org/wp-content/uploads/2023/09/cropped-favicon_light-32x32.png Ivermectina – ACMS | Academia de Ciencias Médicas de Santa Fe https://acacimesfe.org 32 32 Ivermectin is effective for COVID-19: real-time meta analysis of 35 studies https://acacimesfe.org/noticias/ivermectin-is-effective-for-covid-19-real-time-meta-analysis-of-35-studies/ Wed, 03 Feb 2021 13:45:28 +0000 https://acacimesfe.org/?p=7781 We analyze all significant studies concerning the use of ivermectin for COVID-19. Search methods, inclusion criteria, effect extraction criteria...

El cargo Ivermectin is effective for COVID-19: real-time meta analysis of 35 studies apareció primero en ACMS | Academia de Ciencias Médicas de Santa Fe.

]]>
  • 100% of the 35 studies to date report positive effects. Early treatment is more successful, with an estimated reduction of 84% in the effect measured using a random effects meta-analysis, RR 0.16 [0.08-0.33]. Prophylactic use also shows high effectiveness.
  • 100% of the 17 Randomized Controlled Trials (RCTs) report positive effects, with an estimated reduction of 71%, RR 0.29 [0.17-0.51].
  • The probability that an ineffective treatment generated results as positive as the 35 studies to date is estimated to be 1 in 34 billion (p= 0.000000000029).

Leer más…

El cargo Ivermectin is effective for COVID-19: real-time meta analysis of 35 studies apareció primero en ACMS | Academia de Ciencias Médicas de Santa Fe.

]]> Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes https://acacimesfe.org/ivermectina/ivermectin-as-a-potential-drug-for-treatment-of-covid-19-an-in-sync-review-with-clinical-and-computational-attributes/ Thu, 21 Jan 2021 13:54:09 +0000 https://acacimesfe.org/?p=7704 Ivermectin was shown to inhibit severe acute respiratory syndrome corona virus 2 replication in vitro, which has led to off-label use, but clinical efficacy has not been described previously.

El cargo Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes apareció primero en ACMS | Academia de Ciencias Médicas de Santa Fe.

]]>

Información reciente sobre Ivermectina y su posible acción sobre COVID 19 (Enero 2021). Rubén D Piacentini.

Se detallan a continuación trabajos científicos o informes que estaban en prensa o bien que fueron publicados luego del informe anterior sobre este tema.

Leer mas…

El cargo Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes apareció primero en ACMS | Academia de Ciencias Médicas de Santa Fe.

]]> Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019 https://acacimesfe.org/ivermectina/use-of-ivermectin-is-associated-with-lower-mortality-in-hospitalized-patients-with-coronavirus-disease-2019/ Thu, 21 Jan 2021 13:49:25 +0000 https://acacimesfe.org/?p=7698 Ivermectin was shown to inhibit severe acute respiratory syndrome corona virus 2 replication in vitro, which has led to off-label use, but clinical efficacy has not been described previously.

El cargo Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019 apareció primero en ACMS | Academia de Ciencias Médicas de Santa Fe.

]]>

Leer mas…

El cargo Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019 apareció primero en ACMS | Academia de Ciencias Médicas de Santa Fe.

]]> A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness https://acacimesfe.org/ivermectina/a-five-day-course-of-ivermectin-for-the-treatment-of-covid-19-may-reduce-the-duration-of-illness/ Thu, 21 Jan 2021 13:45:10 +0000 https://acacimesfe.org/?p=7695 Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro.

El cargo A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness apareció primero en ACMS | Academia de Ciencias Médicas de Santa Fe.

]]>

Leer mas…

El cargo A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness apareció primero en ACMS | Academia de Ciencias Médicas de Santa Fe.

]]> Ivermectin as a potential drug for treatment of COVID‑19: an in‑sync review with clinical and computational attributes https://acacimesfe.org/ivermectina/ivermectin-as-a-potential-drug-for-treatment-of-covid%e2%80%9119-an-in%e2%80%91sync-review-with-clinical-and-computational-attributes/ Thu, 21 Jan 2021 13:39:58 +0000 https://acacimesfe.org/?p=7689 COVID-19 cases are on surge; however, there is no efcient treatment or vaccine that can be used for its man agement. Numerous clinical trials are being reviewed for use of diferent drugs, biologics, and vaccines in COVID-19. A much empirical approach will be to repurpose existing drugs for which pharmacokinetic and safety data are available...

El cargo Ivermectin as a potential drug for treatment of COVID‑19: an in‑sync review with clinical and computational attributes apareció primero en ACMS | Academia de Ciencias Médicas de Santa Fe.

]]>

Leer mas…

El cargo Ivermectin as a potential drug for treatment of COVID‑19: an in‑sync review with clinical and computational attributes apareció primero en ACMS | Academia de Ciencias Médicas de Santa Fe.

]]>